Wade Gutierrez, MD, PhD

Resident, Mayo Clinic Rochester

Thesis:

Elucidating the Mechanism of a Novel Chemotherapy Regimen for Soft Tissue Sarcomas

2018-2020 - T32 Pre-Doctoral Training Fellowship in Pharmaceutical Sciences (HHS-NIH) NIH T32 GM067795
2020 - HCCC Retreat winner for Clinical Trials & Cancer Outcomes: Epigenetic Combination Therapy Improves Survival in Soft Tissue Sarcoma by a Novel Immune-independent Mechanism
2020 - Midwest Tumor Microenvironment Meeting Young Investigator Award
2016 - Sloan Scholar, Alfred P. Sloan Foundation Minority PhD (MPHD) Program, Sloan Center for Exemplary Mentoring, University of Iowa

Gutierrez WR, Scherer A, Rytlewski JD, Laverty EA, Sheehan AP, McGivney GR, et al. Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism. JCI insight. 2022;7(22). PMC9746804
Gutierrez WR, Scherer A, McGivney GR, Brockman QR, Knepper-Adrian V, Laverty EA, et al. Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models. Scientific reports. 2021;11(1):1098. PMC7806664

BS, Kansas State University; MD and PhD, University of Iowa